Aspen APAC Divestment Unlocks R26.5 Billion For GLP-1 Focus

Shares in Aspen Pharmacare soared by more than 20% at the close of December, following a major strategic pivot. Africa’s largest drugmaker announced a landmark agreement to sell its entire Asia-Pacific (APAC) operations – excluding China – to Australia’s...

GLP-1 Weight Loss Drugs Reshape Obesity Care In South Africa

South Africa’s fight against obesity has entered a decisive phase, driven by a surge in the medicalisation of treatment through GLP-1 weight loss drugs. In early 2026, two major medications, Mounjaro (tirzepatide) and Wegovy (semaglutide), have received key regulatory...

America First Health Funding Strategy Faces East African Test

Uganda has signed a landmark $1.7 billion health sector funding agreement with the United States. This makes it the latest African nation to adopt the America First health funding framework. East Africa now serves as the testing ground for this strategic shift in US...

Medical Tax Credits Debate Sparks Warnings From Policy Experts

The ongoing Medical Tax Credits debate in South Africa has taken a sharp turn. Leading health policy experts push back against calls to eliminate medical tax credits (MTCs) to fund the National Health Insurance (NHI) scheme. Professor Alex van den Heever of the Wits...

Motsoaledi Defends NHI Amid Legal Challenges And Criticism

South African Health Minister Aaron Motsoaledi has launched a strong defence of the National Health Insurance (NHI) scheme. He positions it as a moral and practical necessity for achieving universal health coverage. Speaking in Pretoria during a Universal Health...